LAPTM5 and glioblastoma: To examine the relevance of LAPTM5 in the mediation of treatment resistance to standard therapy for glioblastoma patients, the efficacy of temozolomide chemotherapy was further analyzed according to LAPTM5 status in CD40-expressing U87MG cells.